- Co-founder and non-executive chair of the board of directors of Rallybio LLC.
- Member of the board of directors of Charles River Laboratories International, Inc.
- Member of the board of directors of SpringWorks Therapeutics, Inc.
- Scientific Advisor at Pivotal BioVenture Partners
- Member of the External Advisory Board of Boston Children’s Hospital
- CEO from 2018-2023 and Executive Chairman 2018-2024 of RallyBio LLC.
- President of global research and development at AstraZeneca plc., 2010-2013.
- President and senior vice president within Research and Development, and other roles, Pfizer, Inc., 1995-2010.
- Visiting professor at the Department of Pharmacy at King’s College, London, 1998-2006 and at the Department of Biomedical Sciences at the University of Lincoln, 1998-2014.
- Considered independent under the Danish Corporate Governance Recommendations.
- Member of the Board of Directors since March 2018. Most recently elected in 2025 for a term of one year.
- Chair of the Research & Development Committee since March 2018.
- Member of the Remuneration Committee since March 2021.
- Global corporate leadership.
- Healthcare and pharma industry.
- Medicine & science.
- Technology, data & digital.
- Business development, M&A and external innovation sourcing.
- Human capital management.
- 1984: Doctorate/PhD, University of Edinburgh, UK.
- 1979: BSc (First Class Honours) in Microbiology, Heriot-Watt University, Edinburgh, UK.
American and British, born 1956. Male.
